LONDON, Jan 6 (Reuters) – Johnson & Johnson has
started clinical trials of its experimental Ebola vaccine, which
uses a booster from Denmark’s Bavarian Nordic, making
it the third such shot to enter human testing.
The initiation of the Phase I study, which had been expected
about now, marks further progress in the race to develop a
vaccine against a disease has killed more than 8,000 people in
West Africa since last year.
LONDON, Jan 1 (Reuters) – U.S. drug approvals in 2014 hit
their highest level in 18 years and recommendations in Europe
also came at a rapid rate, driven by expensive new treatments
for cancer and rare diseases.
After suffering a wave of patent losses on blockbuster
products, which peaked two years ago, drugmakers are recovering
their ability to bring new medicines to market and productivity